The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121552912 12155291 2 F 201105 20160627 20160307 20160711 EXP DE-BIOGEN-2013BI015394 BIOGEN MENKE A, LUCKNER K, WITTKUGEL O, TERBORG C, ROSENKRANZ T. BENIGN COURSE OF JC VIRUS-ASSOCIATED CEREBELLAR ATROPHY AFTER LONG-TERM TREATMENT WITH NATALIZUMAB IN A PATIENT WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS. AKT NEUROL. 2016;43:318-321. 40.94 YR F Y 74.00000 KG 20160711 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121552912 12155291 1 PS TYSABRI NATALIZUMAB 1 Intravenous (not otherwise specified) Y 125104 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION
121552912 12155291 2 C thyroxin-jodid 2 Unknown 0 UNKNOWN QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121552912 12155291 1 Multiple sclerosis
121552912 12155291 2 Hypothyroidism

Outcome of event

Event ID CASEID OUTC COD
121552912 12155291 HO
121552912 12155291 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
121552912 12155291 Gait disturbance
121552912 12155291 Gastritis
121552912 12155291 Immune reconstitution inflammatory syndrome
121552912 12155291 JC virus granule cell neuronopathy
121552912 12155291 Myelitis
121552912 12155291 Progressive multifocal leukoencephalopathy
121552912 12155291 Vertigo
121552912 12155291 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121552912 12155291 1 20080130 20130207 0